Latest Stories
Why Myriad Genetics (MYGN) Stock Is Up Today
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 0.4% in the afternoon session after the company shared a positive outlook, projecting significant revenue from its hereditary cancer testing division and outlining its growth targets for the coming years. Myriad Genetics projected approximately $370 million in revenue from this testing segment for the year, accounting for about 45% of its total sales. The company also targeted a growth rate in the high single-digits to low double-digits over the next three to five years. To help achieve these goals, it was supported by a $35 million investment aimed at enhancing its commercial capabilities.
Williams-Sonoma’s (NYSE:WSM) Q3 CY2025: Beats On Revenue But Stock Drops
Kitchenware and home goods retailer Williams-Sonoma (NYSE:WSM) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.6% year on year to $1.88 billion. Its GAAP profit of $1.96 per share was 4.7% above analysts’ consensus estimates.
Stocks making big moves yesterday: Netflix, Cogent, J&J Snack Foods, CarMax, and National Vision
Check out the companies making headlines yesterday:
Griffon’s (NYSE:GFF) Q3 CY2025: Beats On Revenue
Multi-industry consumer and professional products manufacturer Griffon Corporation (NYSE:GFF) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $662.2 million. On the other hand, the company’s full-year revenue guidance of $2.5 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1.54 per share was 1.7% above analysts’ consensus estimates.
TJX (NYSE:TJX) Surprises With Q3 CY2025 Sales
Off-price retail company TJX (NYSE:TJX) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 7.5% year on year to $15.12 billion. On the other hand, next quarter’s revenue guidance of $17.2 billion at the midpoint was less impressive, coming in below analysts’ estimates. Its GAAP profit of $1.28 per share was 5% above analysts’ consensus estimates.
1 Oversold Stock Ready to Bounce Back and 2 We Avoid
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
3 Industrials Stocks That Fall Short
Whether you see them or not, industrials businesses play a crucial part in our daily activities. But this role also comes with a demand profile tethered to the ebbs and flows of the broader economy. Thankfully, industrial end markets were stable over the past six months as the industry’s 9.7% gain has nearly mirrored the S&P 500.
3 Cash-Producing Stocks We Steer Clear Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
3 Growth Stocks to Add to Your Roster
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.